According to an article from The Record posted on NorthJersey.com, the Ovarian National Alliance released a report, the first of its kind, in which it rates each state, as well as the District of Columbia, regarding ovarian cancer care based on the programs, policies, and laws that affect ovarian cancer patients within that state. The report ranks New Jersey as 14th in the nation relative to “treatment” of this disease.
The conditions that placed New Jersey in the top quarter of all states include state laws that provide women with insurance coverage for seeking a second opinion, as well as for routine costs of care during clinical trials, and off-label drug-use. In addition, the New Jersey government also supports research through voluntary tax contributions and the sales of license plates raising cancer awareness. However, there is no law guaranteeing insurance coverage for diagnostic tests.
This year, more than 710 women will be diagnosed with ovarian cancer in New Jersey. The disease is often fatal. A woman’s prognosis is directly tied to various factors including: timely and correct diagnosis, as well as effective treatment. Unfortunately, many healthcare professionals fail to meet the accepted standards of the medical community relative to one or all of these factors.
If you or a loved one has suffered as the result of a healthcare professional’s failure to diagnose ovarian cancer in a timely manner, or their shortcomings in treating ovarian cancer, you may have cause for seeking legal recourse.
To determine whether you may have a meritorious claim, contact the experienced NJ failure to diagnose ovarian cancer lawyers at Blume Forte at (973) 635-5400 for a no-cost consultation regarding your legal rights and potential options.